Filing Flows › Celularity (CELU) › Q2 2025
Celularity (CELU) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 29, 2025
Celularity (CELU) reported revenue of $5.7M for the second quarter 2025 (Q2 2025), -53% from a year earlier and -50% from the quarter before. Operating margin was -276.6%, net loss $24.5M (427.5% of revenue).
Celularity, Q2 2025: revenue $5.7M (-53% year over year), operating margin -276.6%, net loss $24.5M, operating cash flow −$999K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.7M | -50% | -53% |
| Operating profit | −$15.9M | — | — |
| Net earnings | −$24.5M | — | — |
| Operating cash flow | −$999K | — | — |
What changed
Revenue was $5.7M in Q2 2025, down 53% year over year and down 50% from the previous quarter. Product was the largest line at 41% of revenue. Product lost $7.6M year over year (down 76%), 119% of the total change.
Operating costs exceeded revenue by $15.9M, an operating margin of -276.6%. Total costs fell 3% while revenue fell 53%. The fastest-growing cost line was Cost of revenue (+147%). The quarter ended with a net loss of $24.5M, wider than the previous quarter's $19.8M loss.
Operating cash flow was −$1.0M. Non-cash charges added back $1.8M of depreciation and amortization. Working capital and other items added $21.7M.
Questions
What was Celularity's revenue in the second quarter 2025?
Celularity (CELU) reported revenue of $5.7M for the second quarter 2025 (Q2 2025), -53% from a year earlier and -50% from the quarter before.
Was Celularity profitable in the second quarter 2025?
Operating loss was $15.9M (-276.6% of revenue) and net loss $24.5M.
Source: Celularity 10-Q on SEC EDGAR.